NEUROGENE INC (NGNE)

US64135M1053 - Common Stock

22.64  +0.57 (+2.56%)

After market: 22.64 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
25M
-100.00%
939.247K
-100.00%
35.36M258.06M
629.81%
369.39M
43.14%
567.76M
53.70%
787.4M
38.69%
EBITDA
YoY % growth
N/A
-54.74%
N/A
-33.79%
N/AN/A-39.28M
-69.17%
-61.924M
-45.67%
N/A
3.12%
N/A
9.07%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-37.65M
-76.43%
-51.12M
-35.78%
-32.62M
36.19%
-84.66M
25.08%
-42.491M
-70.05%
-63.373M
-46.05%
-57.256M
2.64%
-57.46M
5.95%
-82.778M
-48.93%
-97.005M
-17.19%
-110.928M
-14.35%
-110.67M
0.23%
-119.748M
-8.20%
-123.012M
-2.73%
-127.908M
-3.98%
74.664M
158.37%
Operating Margin
N/AN/A-130.48%N/AN/AN/AN/AN/A-8,813.24%N/AN/A-312.98%-46.40%-33.30%-22.53%9.48%
EPS
YoY % growth
-1.96
-13.29%
-2.14
-9.18%
-1.35
36.92%
-53.86
44.44%
-14.59
-8.00%
-22.94
-171.13%
-20.09
-300.70%
-5.69
35.36%
-4.43
22.20%
-4.42
0.16%
-5.69
-28.69%
N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.15
23.67%
-1.09
-8.80%
-1.11
-2.00%
-1.16
2.29%
-1.20
-4.42%
-1.39
-27.50%
-1.31
-17.43%
-1.34
-14.91%
-1.36
-12.71%
Revenue
Q2Q % growth
N/AN/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-22.713M
28.61%
-22.809M
-22.11%
-23.652M
-17.47%
-24.534M
-10.61%
-25.457M
-12.08%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-1.19
-190.24%
-1.250.064.50%
Q2 2024
Q2Q % growth
-1.09
-2,571.57%
-1.07-0.02-1.77%
Q1 2024
Q2Q % growth
-1.00
80.47%
-1.160.1613.62%
Q4 2023
Q2Q % growth
-1.51
68.54%
-1.20-0.31-26.17%
Q3 2023
Q2Q % growth
-0.41
65.83%
-0.03-0.38-1,239.87%
Q2 2023
Q2Q % growth

97.09%
-0.04%
Q1 2023
Q2Q % growth
-5.12
-265.71%
-2.55-2.57-100.78%
Q4 2022
Q2Q % growth
-4.80
-248.80%
-3.88-0.92-23.84%
Q3 2022
Q2Q % growth
-1.20
-328.57%
-1.550.3522.67%
Q2 2022
Q2Q % growth
-1.40
-418.52%
-1.530.138.50%
Q1 2022
Q2Q % growth
-1.40
-418.52%
-1.510.117.47%
Q4 2021
Q2Q % growth
-1.38
-473.40%
-1.510.138.75%
Q3 2021
Q2Q % growth
-0.28
-47.37%
-0.280.001.37%
Q2 2021
Q2Q % growth
-0.27
-35.00%
-0.270.00-1.03%
Q1 2021
Q2Q % growth
-0.27
-50.00%
-0.23-0.04-16.10%
Q4 2020
Q2Q % growth
-0.24
-9.09%
-0.260.026.51%
Q3 2020
Q2Q % growth
-0.19
56.82%
-0.220.0315.33%
Q2 2020
Q2Q % growth
-0.20 -0.210.016.63%
Q1 2020
Q2Q % growth
-0.18
-100.00%
-0.240.0625.22%
Q4 2019
Q2Q % growth
-0.22
-4.76%
-0.380.1641.71%
Q3 2019
Q2Q % growth
-0.44
31.25%
-0.04-0.40-978.43%
Q2 2019
Q2Q % growth
0.00
-100.00%
-0.050.05100.00%
Q1 2019
Q2Q % growth
-0.09
85.48%
-0.230.1461.64%
Q4 2018
Q2Q % growth
-0.21 -0.810.6073.94%
Q3 2018
Q2Q % growth
-0.64 -0.21-0.43-198.79%
Q2 2018
Q2Q % growth
0.12 -0.120.24198.04%
Q1 2018
Q2Q % growth
-0.62 -0.670.057.90%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2019
Q2Q % growth

-100.00%
%
Q2 2018
Q2Q % growth
25M 12.75M12.25M96.08%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS2.73% -5.28% 1.59% 1.97%
RevenueN/A N/A 102.75% 102.75%